Grant Zeng, CFA
Research analyst, CFA, biotech, small-cap

Galena: Why We Think There Is More Room For Significant Share Price Appreciation

We initiated coverage of Galena Biopharma (NASDAQ:GALE) in mid-November 2011. At that time, the share price of GALE was at about $0.70 per share. As of July 29, 2013, the share price of GALE is $1.77, an appreciation of 153%.

We think the impressive appreciation of share price has been based on many positive d...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
You are protected by the Seeking Alpha Money Back Guarantee and will get a prompt refund on the unused portion of your subscription at any time, for any reason.